Coldrif Children Deaths
- All
- News
- Videos
-
Safety Lapses, Weak Oversight Being Probed Into Cough Syrup Deaths: Report
Officials are investigating whether safety lapses in the supply of a pharmaceutical ingredient were responsible for contaminating cough syrup that has killed at least 24 children in recent months, according to three people familiar with the matter.
-
India 'Has Much To Do' To Stop Toxic Cough Syrup Sales, Says WHO
India has more work to do in halting sales of toxic cough syrup, despite some progress, a World Health Organisation official told Reuters, after at least 24 children died following consumption of a domestically-made medicine.
-
For Every Bottle Of Killer Cough Syrup Doctor Prescribed, He Got Rs 2.5 As Cut
How would you price the life of a child? How would you assess its worth? For the doctor who prescribed the cough syrup to most of the 23 children who died after having it in Madhya Pradesh, the answer was simple: Rs 2.54.
-
Coldrif, Respifresh TR And ReLife: WHO Issues Global Warning Against These Three Indian Cough Syrups
WHO has asked the national regulatory authorities worldwide to report if these medicines are detected in their country immediately.
-
Licence Of Tamil Nadu Firm Behind 'Killer' Cough Syrup Revoked
The Tamil Nadu Drug Control department has revoked the complete licence of Sresan Pharma, which manufactured 'Coldrif' cough syrup that led to the deaths of several children across India.
-
Cough Syrup Linked To Child Deaths In India Not Shipped To US: Drug Regulator
The US Food and Drug Administration confirmed on Friday that toxic cough syrups linked to children's deaths in India had not been shipped to the United States.
-
Coldrif Cough Syrup Deaths: Pharma Firm Owner Sent To 10-Day Police Custody
A Parasia court on Friday sent Sresan Pharma owner Ranganathan to 10-day police custody in connection with the deaths of children allegedly caused by the consumption of Coldrif cough syrup.
-
Amid Cough Syrup Deaths, Madhya Pradesh Blames Tamil Nadu, Alleges Negligence
Madhya Pradesh still reeling from the devastating Coldrif cough syrup tragedy which has claimed the lives of 23 children, Chief Minister Dr. Mohan Yadav has directly blamed the Tamil Nadu government.
-
WHO Flags "Regulatory Gap", Export Risks After Cough Syrup Tragedy
Amid the nationwide outrage over children's deaths caused by adulterated cough syrups in Madhya Pradesh and Rajasthan, the World Health Organization (WHO) has expressed concern over the "regulatory gap" in screening
-
Operation Midnight: How Owner Of Pharma Firm Behind Syrup Tragedy Was Arrested
The pharmaceutical company owner, the key accused in the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh, was arrested by the state police after a dramatic midnight operation.
-
Pharma Firm Owner Arrested Over 20 Children's Deaths Linked To Coldrif Syrup
The owner of the Tamil Nadu-based pharmaceuticals company that manufactured the adulterated Coldrif cough syrup linked to dozens of children's deaths in several states has been detained.
-
'Many Drug Companies Should Have Been Banned', Says Doctors' Group In Toxic Cough Syrup Case
Coldrif, now referred to as the "killer syrup," was recently examined by drug control authorities in Tamil Nadu. On October 2, the authorities declared that the samples were found to be adulterated, containing an alarming 48.6% weight/volume of DEG.
-
Exclusive: How Madhya Pradesh's Drug System Failed To Stop A 'Killer' Syrup
In Madhya Pradesh, 20 children are dead and seven more are battling for life after consuming a toxic cough syrup that should never have reached them.
-
'Doctor Scapegoat To Quell Outrage': Medical Body On Cough Syrup Deaths
A doctor is being made the scapegoat for the cough syrup tragedy in Madhya Pradesh, and those approving such drugs must face action, an all-India organisation of doctors has said.
-
Toxic Cough Syrup, Deadly Fallout: Here's How The Public Health Crisis Unfolded
What began with a few strange deaths linked to cough syrups rapidly snowballed into a multi-state public health and regulatory crisis. Here's how.
-
Safety Lapses, Weak Oversight Being Probed Into Cough Syrup Deaths: Report
Officials are investigating whether safety lapses in the supply of a pharmaceutical ingredient were responsible for contaminating cough syrup that has killed at least 24 children in recent months, according to three people familiar with the matter.
-
India 'Has Much To Do' To Stop Toxic Cough Syrup Sales, Says WHO
India has more work to do in halting sales of toxic cough syrup, despite some progress, a World Health Organisation official told Reuters, after at least 24 children died following consumption of a domestically-made medicine.
-
For Every Bottle Of Killer Cough Syrup Doctor Prescribed, He Got Rs 2.5 As Cut
How would you price the life of a child? How would you assess its worth? For the doctor who prescribed the cough syrup to most of the 23 children who died after having it in Madhya Pradesh, the answer was simple: Rs 2.54.
-
Coldrif, Respifresh TR And ReLife: WHO Issues Global Warning Against These Three Indian Cough Syrups
WHO has asked the national regulatory authorities worldwide to report if these medicines are detected in their country immediately.
-
Licence Of Tamil Nadu Firm Behind 'Killer' Cough Syrup Revoked
The Tamil Nadu Drug Control department has revoked the complete licence of Sresan Pharma, which manufactured 'Coldrif' cough syrup that led to the deaths of several children across India.
-
Cough Syrup Linked To Child Deaths In India Not Shipped To US: Drug Regulator
The US Food and Drug Administration confirmed on Friday that toxic cough syrups linked to children's deaths in India had not been shipped to the United States.
-
Coldrif Cough Syrup Deaths: Pharma Firm Owner Sent To 10-Day Police Custody
A Parasia court on Friday sent Sresan Pharma owner Ranganathan to 10-day police custody in connection with the deaths of children allegedly caused by the consumption of Coldrif cough syrup.
-
Amid Cough Syrup Deaths, Madhya Pradesh Blames Tamil Nadu, Alleges Negligence
Madhya Pradesh still reeling from the devastating Coldrif cough syrup tragedy which has claimed the lives of 23 children, Chief Minister Dr. Mohan Yadav has directly blamed the Tamil Nadu government.
-
WHO Flags "Regulatory Gap", Export Risks After Cough Syrup Tragedy
Amid the nationwide outrage over children's deaths caused by adulterated cough syrups in Madhya Pradesh and Rajasthan, the World Health Organization (WHO) has expressed concern over the "regulatory gap" in screening
-
Operation Midnight: How Owner Of Pharma Firm Behind Syrup Tragedy Was Arrested
The pharmaceutical company owner, the key accused in the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh, was arrested by the state police after a dramatic midnight operation.
-
Pharma Firm Owner Arrested Over 20 Children's Deaths Linked To Coldrif Syrup
The owner of the Tamil Nadu-based pharmaceuticals company that manufactured the adulterated Coldrif cough syrup linked to dozens of children's deaths in several states has been detained.
-
'Many Drug Companies Should Have Been Banned', Says Doctors' Group In Toxic Cough Syrup Case
Coldrif, now referred to as the "killer syrup," was recently examined by drug control authorities in Tamil Nadu. On October 2, the authorities declared that the samples were found to be adulterated, containing an alarming 48.6% weight/volume of DEG.
-
Exclusive: How Madhya Pradesh's Drug System Failed To Stop A 'Killer' Syrup
In Madhya Pradesh, 20 children are dead and seven more are battling for life after consuming a toxic cough syrup that should never have reached them.
-
'Doctor Scapegoat To Quell Outrage': Medical Body On Cough Syrup Deaths
A doctor is being made the scapegoat for the cough syrup tragedy in Madhya Pradesh, and those approving such drugs must face action, an all-India organisation of doctors has said.
-
Toxic Cough Syrup, Deadly Fallout: Here's How The Public Health Crisis Unfolded
What began with a few strange deaths linked to cough syrups rapidly snowballed into a multi-state public health and regulatory crisis. Here's how.
